Yağmur Kara
Yağmur Kara has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Zafer Usta
Department of Genetics, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey
3 shared publications - Şakir Pekgöz
Department of Medical Services and Techniques, Isparta Health Services Vocational School, Süleyman Demirel University, 32260, Isparta, Turkey
3 shared publications - Ozlem Ozmen
Department of Pathology, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey
2 shared publications - Adnan Karaibrahimoglu
Süleyman Demirel Üniversitesi
1 shared publication - Berit Gökçe Ceylan
Süleyman Demirel Üniversitesi
1 shared publication - Füsun Eroğlu
SÜLEYMAN DEMİREL ÜNİVERSİTESİ, TIP FAKÜLTESİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ
1 shared publication
Latest Publications
- 10 August 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (11) , 1479-1487
Oleuropein modulates apoptotic and endothelial-associated markers in a radiation-induced acute renal injury model in rats
1. Radiation therapy remains a cornerstone in the treatment of various malignancies; however, radiation-induced renal injury (RIN) is a progressive condition characterized by oxidative stress, infl...
- 10 August 2026
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (11) , 1479-1487
Oleuropein modulates apoptotic and endothelial-associated markers in a radiation-induced acute renal injury model in rats
1. Radiation therapy remains a cornerstone in the treatment of various malignancies; however, radiation-induced renal injury (RIN) is a progressive condition characterized by oxidative stress, infl...
- Open Access
- 24 March 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (9) , 13319-13330
L-carnitine protects against methotrexate-induced hepatotoxicity via regulation of apoptosis and metabolic pathways
Methotrexate (MTX) is a widely used chemotherapeutic and immunosuppressive drug; however, its clinical application is limited by dose-dependent hepatotoxicity mediated by oxidative stress, mitochondrial dysfunction, and apoptosis. This study aimed to investigate the potential hepatoprotective effects of L-carnitine (LCR), a mitochondrial cofactor with antioxidant and anti-apoptotic properties, in a rat model of MTX-induced hepatotoxicity. Twenty-four male Wistar rats were randomly divided into four groups: Control, MTX (20 mg/kg, i.p., single dose), LCR (100 mg/kg/day, oral) and MTX + LCR. After 10 days, liver tissues were examined histopathologically, immunohistochemically for CD38 and GLUT1, and by qPCR for BAX and BCL2 expression. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were also measured. MTX administration induced histological injury, upregulated CD38 and GLUT1 expression and altered apoptosis-related genes (BAX↑, BCL2↓) with a trend toward elevated ALT and AST levels. LCR co-treatment improved hepatic histoarchitecture, reduced CD38 and GLUT1 expression and partially normalized BAX/BCL2 expression, with a tendency to restore serum enzyme activity. L-carnitine may attenuate MTX-induced hepatotoxicity by modulating oxidative stress, metabolic stress and apoptotic signaling. These findings suggest a potential role for L-carnitine as an adjuvant to improve hepatic safety during MTX therapy.
- 24 March 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (9) , 13319-13330
Open AccessL-carnitine protects against methotrexate-induced hepatotoxicity via regulation of apoptosis and metabolic pathways
Methotrexate (MTX) is a widely used chemotherapeutic and immunosuppressive drug; however, its clinical application is limited by dose-dependent hepatotoxicity mediated by oxidative stress, mitochondrial dysfunction, and apoptosis. This study aimed to investigate the potential hepatoprotective effects of L-carnitine (LCR), a mitochondrial cofactor with antioxidant and anti-apoptotic properties, in a rat model of MTX-induced hepatotoxicity. Twenty-four male Wistar rats were randomly divided into four groups: Control, MTX (20 mg/kg, i.p., single dose), LCR (100 mg/kg/day, oral) and MTX + LCR. After 10 days, liver tissues were examined histopathologically, immunohistochemically for CD38 and GLUT1, and by qPCR for BAX and BCL2 expression. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were also measured. MTX administration induced histological injury, upregulated CD38 and GLUT1 expression and altered apoptosis-related genes (BAX↑, BCL2↓) with a trend toward elevated ALT and AST levels. LCR co-treatment improved hepatic histoarchitecture, reduced CD38 and GLUT1 expression and partially normalized BAX/BCL2 expression, with a tendency to restore serum enzyme activity. L-carnitine may attenuate MTX-induced hepatotoxicity by modulating oxidative stress, metabolic stress and apoptotic signaling. These findings suggest a potential role for L-carnitine as an adjuvant to improve hepatic safety during MTX therapy.
- 11 February 2026
- Published by Wiley in Journal of Applied Toxicology
- Vol. 46 (9) , 3034-3042
Agomelatine Alleviates Methotrexate‐Induced Lung Injury by Concurrently Inhibiting CD45/CD68‐Positive Immune Cell Infiltration and Modulating the BAX/BCL2 Apoptosis Pathway
Methotrexate (MTX)‐induced pulmonary toxicity severely limits its clinical use and effective preventive strategies are lacking. This study evaluated the protective effects of agomelatine (AGO), a melatonergic antidepressant, against MTX‐induced lung injury, focusing on its dual‐pathway action targeting both immune cell infiltration and apoptotic signaling. Thirty‐two female Wistar rats were assigned to: Control, AGO (20 mg/kg/day, p.o., 7 days), MTX (single i.p. dose, 20 mg/kg), and MTX + AGO groups. Lung tissues were examined by histopathology, immunohistochemistry (CD45 + , CD68 + ), and RT‐qPCR (BAX, BCL2). MTX administration caused marked pulmonary damage (histopathological score: 2.75 ± 0.25, p < 0.001), significant infiltration of CD45 + leukocytes and CD68 + macrophages and an elevated BAX/BCL2 ratio (3.5 ± 0.4 vs. 1.0 ± 0.2 in Control, p < 0.001). AGO cotreatment significantly ameliorated these alterations via its dual activity, lowering the histopathological score (1.25 ± 0.25, p < 0.01), reducing CD45 + /CD68 immunopositivity, and restoring the BAX/BCL2 ratio toward cell survival (1.4 ± 0.3, p < 0.01 vs. MTX). These findings provide integrated immunohistochemical and molecular evidence supporting the concurrent modulation of immune cell infiltration and apoptotic signaling by AGO in MTX‐induced lung injury. Given its established clinical use and favorable safety profile, AGO may represent a potential adjunctive candidate to reduce the risk of MTX‐related pulmonary complications, through concurrent targeting of immune and apoptotic pathways.
- 11 February 2026
- Published by Wiley in Journal of Applied Toxicology
- Vol. 46 (9) , 3034-3042
Agomelatine Alleviates Methotrexate‐Induced Lung Injury by Concurrently Inhibiting CD45/CD68‐Positive Immune Cell Infiltration and Modulating the BAX/BCL2 Apoptosis Pathway
Methotrexate (MTX)‐induced pulmonary toxicity severely limits its clinical use and effective preventive strategies are lacking. This study evaluated the protective effects of agomelatine (AGO), a melatonergic antidepressant, against MTX‐induced lung injury, focusing on its dual‐pathway action targeting both immune cell infiltration and apoptotic signaling. Thirty‐two female Wistar rats were assigned to: Control, AGO (20 mg/kg/day, p.o., 7 days), MTX (single i.p. dose, 20 mg/kg), and MTX + AGO groups. Lung tissues were examined by histopathology, immunohistochemistry (CD45 + , CD68 + ), and RT‐qPCR (BAX, BCL2). MTX administration caused marked pulmonary damage (histopathological score: 2.75 ± 0.25, p < 0.001), significant infiltration of CD45 + leukocytes and CD68 + macrophages and an elevated BAX/BCL2 ratio (3.5 ± 0.4 vs. 1.0 ± 0.2 in Control, p < 0.001). AGO cotreatment significantly ameliorated these alterations via its dual activity, lowering the histopathological score (1.25 ± 0.25, p < 0.01), reducing CD45 + /CD68 immunopositivity, and restoring the BAX/BCL2 ratio toward cell survival (1.4 ± 0.3, p < 0.01 vs. MTX). These findings provide integrated immunohistochemical and molecular evidence supporting the concurrent modulation of immune cell infiltration and apoptotic signaling by AGO in MTX‐induced lung injury. Given its established clinical use and favorable safety profile, AGO may represent a potential adjunctive candidate to reduce the risk of MTX‐related pulmonary complications, through concurrent targeting of immune and apoptotic pathways.
- Open Access
- 22 October 2025
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (3) , 282-286
RETROSPECTIVE REVIEW OF THE ROLE OF PREGABALIN IN PREOPERATIVE PAIN MANAGEMENT: MECHANISMS OF ACTION AND CLINICAL OUTCOMES
Objective: Infraclavicular block is a commonly utilized technique in hand and forearm surgeries. Pregabalin, acknowledged for its efficacy in managing neuropathic and chronic pain, has emerged as a potential intervention for reducing postoperative pain when administered preoperatively. This study aimed to evaluate the impact of a single 150 mg dose of pregabalin, administered one hour prior to surgery, on block characteristics and postoperative analgesia requirement in patients undergoing hand and forearm surgery with infraclavicular block. Methods: The medical records of patients aged 18-65 years, classified as ASA I-II, who underwent hand and forearm surgeries under infraclavicular block, were retrospectively analyzed. All patients received regional antisepsis, a 30 ml volume (Bupivacaine+Lidocaine) was administered, and an ultrasound-guided infraclavicular block was performed. Patients were categorized into two groups: the pregabalin group (Group P), comprising 30 patients who received preemptive anesthesia with 150 mg pregabalin, and the control group (Group C), consisting of 30 patients who did not receive pregabalin. Hemodynamic parameters, postoperative pain intensity, time of initial pain onset, and time of first analgesic requirement were documented based on anesthesia records and patient follow-up forms. Results: Postoperative visual analog scale scores were lower in Group P at the 12th and 24th hours (p
- 22 October 2025
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (3) , 282-286
Open AccessRETROSPECTIVE REVIEW OF THE ROLE OF PREGABALIN IN PREOPERATIVE PAIN MANAGEMENT: MECHANISMS OF ACTION AND CLINICAL OUTCOMES
Objective: Infraclavicular block is a commonly utilized technique in hand and forearm surgeries. Pregabalin, acknowledged for its efficacy in managing neuropathic and chronic pain, has emerged as a potential intervention for reducing postoperative pain when administered preoperatively. This study aimed to evaluate the impact of a single 150 mg dose of pregabalin, administered one hour prior to surgery, on block characteristics and postoperative analgesia requirement in patients undergoing hand and forearm surgery with infraclavicular block. Methods: The medical records of patients aged 18-65 years, classified as ASA I-II, who underwent hand and forearm surgeries under infraclavicular block, were retrospectively analyzed. All patients received regional antisepsis, a 30 ml volume (Bupivacaine+Lidocaine) was administered, and an ultrasound-guided infraclavicular block was performed. Patients were categorized into two groups: the pregabalin group (Group P), comprising 30 patients who received preemptive anesthesia with 150 mg pregabalin, and the control group (Group C), consisting of 30 patients who did not receive pregabalin. Hemodynamic parameters, postoperative pain intensity, time of initial pain onset, and time of first analgesic requirement were documented based on anesthesia records and patient follow-up forms. Results: Postoperative visual analog scale scores were lower in Group P at the 12th and 24th hours (p
- Open Access
- 20 June 2023
- Published by European Mechanical Science in European Mechanical Science
- Vol. 7 (2) , 89-98
Prediction of absorption dose of radiation on Thorax CT imaging in geriatric patients with COVID-19 by classification algorithms
Objective: The aim of the study is to predict the absorbed radiation dose on thorax CT imaging in geriatric patients with COVID-19. Materials and Method: The SIEMENS SENSATION 64 CT scanner was performed with real protocols to patients (male/female phantom) using Monte Carlo simulation methods with the patient’s real height and weight nts and the actual parameters CT scanner. Absorbed organ doses have been calculated based on these Monte Carlo results. These results were used to predict the optimal absorbed radiation dose by Artificial Neural Network, Linear Discriminant Analysis, Random Forest Classification, and Naive-Bayes Classification algorithms. The dose values were clustered for genders by the Fuzzy C-Means algorithm. Results: The ages of the patients were between 60 and 70 years. The Body Mass Indexes of male and female patients were 26.11 ± 4.49 and 25.03 ± 4.86 kg/m2 respectively. All classification algorithms were validated with approximately 100% success. The Fuzzy C-Means technique was found to be successful in clustering the dose values for gender clusters. Conclusion: While the predicted and the observed values of patients do not change in the organs/tissues around and outside of the thorax, they generally vary in the intra-thoracic organs and tissues. It can be concluded that data-driven techniques are useful to obtain optimal radiation doses for organs/tissues in CT imaging.
- 20 June 2023
- Published by European Mechanical Science in European Mechanical Science
- Vol. 7 (2) , 89-98
Open AccessPrediction of absorption dose of radiation on Thorax CT imaging in geriatric patients with COVID-19 by classification algorithms
Objective: The aim of the study is to predict the absorbed radiation dose on thorax CT imaging in geriatric patients with COVID-19. Materials and Method: The SIEMENS SENSATION 64 CT scanner was performed with real protocols to patients (male/female phantom) using Monte Carlo simulation methods with the patient’s real height and weight nts and the actual parameters CT scanner. Absorbed organ doses have been calculated based on these Monte Carlo results. These results were used to predict the optimal absorbed radiation dose by Artificial Neural Network, Linear Discriminant Analysis, Random Forest Classification, and Naive-Bayes Classification algorithms. The dose values were clustered for genders by the Fuzzy C-Means algorithm. Results: The ages of the patients were between 60 and 70 years. The Body Mass Indexes of male and female patients were 26.11 ± 4.49 and 25.03 ± 4.86 kg/m2 respectively. All classification algorithms were validated with approximately 100% success. The Fuzzy C-Means technique was found to be successful in clustering the dose values for gender clusters. Conclusion: While the predicted and the observed values of patients do not change in the organs/tissues around and outside of the thorax, they generally vary in the intra-thoracic organs and tissues. It can be concluded that data-driven techniques are useful to obtain optimal radiation doses for organs/tissues in CT imaging.